SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Novartis clinical updates pause trials after patient deaths

Novartis said it halted trials for one experimental drug following a spate of patient deaths, while also disclosing positive data for a pill analysts view as a potential blockbuster.

NOT

Novartis released a mixed set of clinical updates, pausing trials of one drug after a spate of patient deaths while also disclosing positive data for a pill that analysts see as a potential blockbuster. The Swiss drugmaker said it had halted trials for its experiment…

Related stories